TrialPloS one2014

No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trial.

Ajantha Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.